Deletions in the 5' region of dystrophin and resulting phenotypes
- PMID: 7853367
- PMCID: PMC1016656
- DOI: 10.1136/jmg.31.11.843
Deletions in the 5' region of dystrophin and resulting phenotypes
Abstract
Deletions in the dystrophin gene give rise to both Duchenne and Becker muscular dystrophies. Good correlation is generally found between the severity of the phenotype and the effect of the deletion on the reading frame: deletions that disrupt the reading frame result in a severe phenotype, while in frame deletions are associated with a milder disease course. Rare exceptions to this rule, mainly owing to frameshift mutations in the 5' region of the gene (in particular deletions involving exons 3 to 7) which are associated with a milder than expected phenotype, have been reported previously. In order to characterise better the relationship between genotype and phenotype as a result of mutations arising in the 5' region of the gene, we have studied a large cohort of patients with small in frame and out of frame deletions in the first 13 exons of the dystrophin gene. Fifty-five patients with a deletion in this area were identified; approximately one third of them had a phenotype different from that theoretically expected. Patients were divided into two groups: (1) patients with a severe clinical phenotype despite the presence of a small, in frame deletion and (2) patients with a mild phenotype and an out of frame deletion. Noticeable examples observed in the first group were Duchenne boys with a deletion of exon 5, of exon 3, and of exons 3-13. In the second group we observed several patients with an intermediate or Becker phenotype and out of frame deletions involving not only the usual exons 3-7 but also 5-7 and 3-6. These data indicate that a high proportion of patients with a deletion in the 5' end of the gene have a phenotype that is not predictable on the basis of the effect of the deletion on the reading frame. The N-terminus of dystrophin has at least one actin binding domain that might be affected by the small, in frame deletions in this area. The effect of the in frame deletions of exon 3, 5, and 3-13 on this domain might account for the severe phenotype observed in these patients. Other mechanisms, such as unexpected effect of the deletion on splicing behaviour, might, however, also be implicated in determining the phenotype outcome.
Similar articles
-
Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy.Hum Mol Genet. 1993 Jun;2(6):737-44. doi: 10.1093/hmg/2.6.737. Hum Mol Genet. 1993. PMID: 8353493
-
Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies.PLoS One. 2016 Jan 8;11(1):e0145620. doi: 10.1371/journal.pone.0145620. eCollection 2016. PLoS One. 2016. PMID: 26745801 Free PMC article.
-
Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene.Am J Hum Genet. 1989 Oct;45(4):507-20. Am J Hum Genet. 1989. PMID: 2491010 Free PMC article.
-
Genetic and clinical correlations of Xp21 muscular dystrophy.J Inherit Metab Dis. 1992;15(4):551-64. doi: 10.1007/BF01799614. J Inherit Metab Dis. 1992. PMID: 1528016 Review.
-
[Molecular genetics and problems found in genetic diagnosis of Duchenne Becker muscular dystrophy].Nihon Rinsho. 1997 Dec;55(12):3120-5. Nihon Rinsho. 1997. PMID: 9436421 Review. Japanese.
Cited by
-
Restoration of the dystrophin-associated glycoprotein complex after exon skipping therapy in Duchenne muscular dystrophy.Mol Ther. 2012 Feb;20(2):462-7. doi: 10.1038/mt.2011.248. Epub 2011 Nov 15. Mol Ther. 2012. PMID: 22086232 Free PMC article.
-
Mechanisms of resistance to pathogenesis in muscular dystrophies.Mol Cell Biochem. 1999 May;195(1-2):155-67. doi: 10.1023/a:1006972315739. Mol Cell Biochem. 1999. PMID: 10395079 Review.
-
The complex landscape of DMD mutations: moving towards personalized medicine.Front Genet. 2024 Mar 26;15:1360224. doi: 10.3389/fgene.2024.1360224. eCollection 2024. Front Genet. 2024. PMID: 38596212 Free PMC article. Review.
-
Microdystrophin Expression as a Surrogate Endpoint for Duchenne Muscular Dystrophy Clinical Trials.Hum Gene Ther. 2023 May;34(9-10):404-415. doi: 10.1089/hum.2022.190. Epub 2023 Mar 14. Hum Gene Ther. 2023. PMID: 36694468 Free PMC article.
-
Becker muscular dystrophy caused by exon 2-truncating mutation of DMD.Hum Genome Var. 2019 Nov 18;6:52. doi: 10.1038/s41439-019-0083-5. eCollection 2019. Hum Genome Var. 2019. PMID: 31754439 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical